Last reviewed · How we verify
GT20029 Gel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
GT20029 Gel (GT20029 Gel) — Suzhou Kintor Pharmaceutical Inc,.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GT20029 Gel TARGET | GT20029 Gel | Suzhou Kintor Pharmaceutical Inc, | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GT20029 Gel CI watch — RSS
- GT20029 Gel CI watch — Atom
- GT20029 Gel CI watch — JSON
- GT20029 Gel alone — RSS
Cite this brief
Drug Landscape (2026). GT20029 Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/gt20029-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab